Hyperprogression following immunotherapy: Myth or reality?

Date 25 November 2018
Event ESMO Asia 2018 Congress
Session Challenges in head and neck oncology
Topics Immunotherapy
Complications/Toxicities of Treatment
Head and Neck Cancers
Presenter Christophe Le Tourneau
Authors C. Le Tourneau
  • Medical Oncology, Institut Curie, 75248 cedex5 - Paris/FR